Quantitative Muscle MRI as an Assessment Tool for Monitoring Disease Progression in LGMD2I: A Multicentre Longitudinal Study

BACKGROUND: Outcome measures for clinical trials in neuromuscular diseases are typically based on physical assessments which are dependent on patient effort, combine the effort of different muscle groups, and may not be sensitive to progression over short trial periods in slow-progressing diseases....

Descripción completa

Detalles Bibliográficos
Autores principales: Willis, Tracey A., Hollingsworth, Kieren G., Coombs, Anna, Sveen, Marie-Louise, Andersen, Søren, Stojkovic, Tanya, Eagle, Michelle, Mayhew, Anna, de Sousa, Paulo L., Dewar, Liz, Morrow, Jasper M., Sinclair, Christopher D. J., Thornton, John S., Bushby, Kate, Lochmüller, Hanns, Hanna, Michael G., Hogrel, Jean-Yves, Carlier, Pierre G., Vissing, John, Straub, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743890/
https://www.ncbi.nlm.nih.gov/pubmed/23967145
http://dx.doi.org/10.1371/journal.pone.0070993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3743890/
https://www.ncbi.nlm.nih.gov/pubmed/23967145
http://dx.doi.org/10.1371/journal.pone.0070993

Ejemplares similares